Vanda Pharmaceuticals (VNDA) Shareholder Highbridge Capital Management Raised Position; Lowe Brockenbrough & Company Cut Its Hess Com (HES) Holding by $756,465; Stock Value Rose

May 21, 2018 - By Clifton Ray

Hess Corporation (NYSE:HES) Logo

Lowe Brockenbrough & Company Inc decreased its stake in Hess Corp Com (HES) by 17.32% based on its latest 2017Q4 regulatory filing with the SEC. Lowe Brockenbrough & Company Inc sold 16,095 shares as the company’s stock rose 6.08% while stock markets declined. The institutional investor held 76,853 shares of the integrated oil company at the end of 2017Q4, valued at $3.65 million, down from 92,948 at the end of the previous reported quarter. Lowe Brockenbrough & Company Inc who had been investing in Hess Corp Com for a number of months, seems to be less bullish one the $19.59 billion market cap company. The stock increased 0.94% or $0.6065 during the last trading session, reaching $65.2665. About 1.71M shares traded. Hess Corporation (NYSE:HES) has risen 8.91% since May 21, 2017 and is uptrending. It has underperformed by 2.64% the S&P500.




Glenn Russell Dubin increased its stake in Vanda Pharmaceuticals Inc (VNDA) by 259.81% based on its latest 2017Q4 regulatory filing with the SEC. Highbridge Capital Management Llc bought 37,673 shares as the company’s stock rose 9.54% while stock markets declined. The hedge fund run by Glenn Russell Dubin held 52,173 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $793,000, up from 14,500 at the end of the previous reported quarter. Highbridge Capital Management Llc who had been investing in Vanda Pharmaceuticals Inc for a number of months, seems to be bullish on the $872.85 million market cap company. The stock decreased 1.47% or $0.25 during the last trading session, reaching $16.75. About 109,950 shares traded. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has risen 15.63% since May 21, 2017 and is uptrending. It has outperformed by 4.08% the S&P500.

Highbridge Capital Management Llc, which manages about $32.39 billion and $5.61 billion US Long portfolio, decreased its stake in Spdr S&P 500 Etf Tr (SPY) by 360,000 shares to 40,000 shares, valued at $10.67 million in 2017Q4, according to the filing. It also reduced its holding in Capital One Finl Corp (Put) (NYSE:COF) by 53,969 shares in the quarter, leaving it with 3,200 shares, and cut its stake in Tyson Foods Inc (NYSE:TSN).

Since January 2, 2018, it had 0 insider purchases, and 8 insider sales for $4.89 million activity. Shares for $159,605 were sold by Birznieks Gunther. Gulino Richard L. also sold $157,565 worth of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Tuesday, January 2. Polymeropoulos Mihael Hristos also sold $1.14 million worth of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Wednesday, February 28.

Investors sentiment decreased to 1.17 in Q4 2017. Its down 0.26, from 1.43 in 2017Q3. It worsened, as 19 investors sold VNDA shares while 34 reduced holdings. 16 funds opened positions while 46 raised stakes. 39.77 million shares or 2.28% more from 38.89 million shares in 2017Q3 were reported. Dekabank Deutsche Girozentrale reported 11,100 shares. Rice Hall James & Limited Liability Company holds 0.02% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) for 28,245 shares. 704,009 were reported by Prudential Financial. Numeric Limited owns 628,000 shares. The New York-based Bnp Paribas Arbitrage Sa has invested 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Panagora Asset Mgmt accumulated 268,534 shares. Swiss Commercial Bank invested in 69,500 shares. Moreover, Point72 Asia (Hong Kong) has 0% invested in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Metropolitan Life Insur Com Ny stated it has 14,516 shares. Qs Ltd Liability holds 325,585 shares or 0.05% of its portfolio. Dupont has invested 0.03% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Bancshares Of Montreal Can accumulated 71,855 shares or 0% of the stock. Retail Bank Of America Corp De accumulated 169,155 shares. Susquehanna Intll Gp Llp invested in 27,448 shares. California Pub Employees Retirement Systems has 0% invested in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA).

Among 8 analysts covering Vanda Pharmaceuticals (NASDAQ:VNDA), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vanda Pharmaceuticals had 24 analyst reports since September 2, 2015 according to SRatingsIntel. The firm has “Buy” rating by Piper Jaffray given on Thursday, August 3. The rating was maintained by Oppenheimer on Thursday, August 3 with “Buy”. As per Monday, March 5, the company rating was maintained by Oppenheimer. As per Monday, June 26, the company rating was maintained by Jefferies. As per Monday, January 8, the company rating was maintained by Oppenheimer. Piper Jaffray initiated Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Tuesday, June 27 with “Buy” rating. The stock of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) earned “Market Outperform” rating by JMP Securities on Wednesday, March 9. H.C. Wainwright maintained the stock with “Buy” rating in Thursday, August 3 report. Oppenheimer maintained Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) on Monday, October 30 with “Outperform” rating. Seaport Global maintained Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rating on Wednesday, February 28. Seaport Global has “Buy” rating and $21.0 target.

More news for Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) were recently published by: Seekingalpha.com, which released: “Vanda Pharmaceuticals’ (VNDA) CEO Mihael Polymeropoulos on Q1 2018 Results – Earnings Call Transcript” on May 03, 2018. Globenewswire.com‘s article titled: “Investor Expectations to Drive Momentum within Plains Group Holdings, EnteroMedics, Vanda Pharmaceuticals …” and published on May 10, 2018 is yet another important article.

Since February 8, 2018, it had 11 buys, and 15 selling transactions for $8.38 million activity. $85,572 worth of stock was sold by Truelove Brian D. on Thursday, February 8. Checki Terrence J. bought 516 shares worth $25,016. Another trade for 1,914 shares valued at $85,039 was sold by Turner Michael R. Shares for $25,016 were bought by MCMANUS DAVID. 516 shares were bought by CHASE RODNEY F, worth $25,016. LAVIZZO-MOUREY RISA J bought 516 shares worth $25,016.

Among 23 analysts covering Hess Corp. (NYSE:HES), 8 have Buy rating, 2 Sell and 13 Hold. Therefore 35% are positive. Hess Corp. had 68 analyst reports since July 22, 2015 according to SRatingsIntel. On Friday, December 15 the stock rating was downgraded by JP Morgan to “Underweight”. UBS downgraded Hess Corporation (NYSE:HES) rating on Thursday, April 28. UBS has “Neutral” rating and $65 target. The firm has “Hold” rating by BMO Capital Markets given on Tuesday, October 10. The rating was upgraded by Societe Generale to “Buy” on Friday, July 31. The firm has “Equal-Weight” rating by Morgan Stanley given on Wednesday, October 18. The company was downgraded on Thursday, April 26 by Macquarie Research. Cowen & Co maintained Hess Corporation (NYSE:HES) on Tuesday, January 16 with “Hold” rating. The firm earned “Hold” rating on Wednesday, April 11 by BMO Capital Markets. The company was initiated on Tuesday, December 15 by Credit Agricole. The rating was maintained by Cowen & Co on Monday, September 25 with “Hold”.

More news for Hess Corporation (NYSE:HES) were recently published by: Seekingalpha.com, which released: “Hess Corporation: Is It Too Late?” on May 21, 2018. Streetinsider.com‘s article titled: “Kosmos Energy (KOS) Provides Suriname Activity Update; Encountered Bore Hole Stability Issues (Earlier)” and published on May 21, 2018 is yet another important article.

Hess Corporation (NYSE:HES) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: